Pricing Log in Create free account

Apimeds Pharmaceuticals US, Inc. (APUS) vs Gelteq Limited (GELS)

Apimeds Pharmaceuticals US, Inc. and Gelteq Limited are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $4.9M against $4.1M — 1.2× the size. Across the 8 metrics below, Gelteq Limited leads on 6 and Apimeds Pharmaceuticals US, Inc. on 2.

Valuation

Metric APUS GELS Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S n/m — 2.08
P/B 0.04 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m n/m 2.87
Earnings yield (1,394.72%) — (15.94%)
Free cash flow yield (295.94%) 0.00% 0.00%

Profitability

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Gross margin — — 53.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (100.13%) 0.00% (0.80%)
Return on assets (84.20%) 0.00% (1.67%)
Return on invested capital (15.96%) 0.00% 0.00%

Growth

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) (205.56%) (62.07%) 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Debt to equity 0.08 0.36 0.04
Current ratio 0.51 0.09 2.41
Net debt to EBITDA 0.38 (0.91) 1.01

Dividend

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric APUS GELS Drug Manufacturers Specialty & Generic median
Market cap 4.12m 4.88m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack